1. Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer. (February 2021) Authors: Wortman, B.G.; Astreinidou, E.; Laman, M.S.; van der Steen-Banasik, E.M.; Lutgens, L.C.H.W.; Westerveld, H.; Koppe, F.; Slot, A.; van den Berg, H.A.; Nowee, M.E.; Bijmolt, S.; Stam, T.C.; Zwanenburg, A.G.; Mens, J.W.M.; Jürgenliemk-Schulz, I.M.; Snyers, A.; Gillham, C.M.; Weidner, N.; Kommoss, S.... Journal: Radiotherapy and oncology Issue: Volume 155(2021) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer. (April 2018) Authors: De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M.H.; Jürgenliemk-Schulz, I.M.; Kitchener, H.C.; Nijman, H.W.; Wilson, G.; Kolodziej, I.; Carinelli, S.; Lutgens, L.C.H.W.; Smit, V.T... Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial. (April 2015) Authors: De Boer, S.M.; Nout, R.A.; Putter, H.; Jürgenliemk-Schulz, I.M.; Jobsen, J.J.; Lutgens, L.C.H.W.; Van der Steen-Banasik, E.M.; Mens, J.W.M.; Slot, A.; Stenfert Kroese, M.C.; Nijman, H.W.; Creutzberg, C.L. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗